Dorzolamide and timolol ophthalmic and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Dorzolamide and timolol ophthalmic and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dorzolamide / timolol ophthalmic
Brand name: Cosopt, Cosopt PF
Synonyms: Dorzolamide and Timolol
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dorzolamide and timolol ophthalmic-Insulin glargine, recombinant Subcutaneous
- Dorzolamide and timolol ophthalmic-Insulin glulisine
- Dorzolamide and timolol ophthalmic-Insulin Glulisine (Cartridges and Pens)
- Dorzolamide and timolol ophthalmic-Insulin Glulisine (Vials)
- Dorzolamide and timolol ophthalmic-Insulin glulisine Subcutaneous
- Dorzolamide and timolol ophthalmic-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Dorzolamide and Timolol Ophthalmic Solution
- Insulin glargine and lixisenatide Subcutaneous-Dorzolamide and Timolol Preservative-Free Eye Drops
- Insulin glargine and lixisenatide Subcutaneous-Dorzolamide Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Dorzolamide ophthalmic
- Insulin glargine and lixisenatide Subcutaneous-Dostinex
- Insulin glargine and lixisenatide Subcutaneous-Dotarem